ENGEL expects revenue of around €1.55 billion for the 2026/27 financial year, an increase of approximately ten per cent on the previous year. The business is performing ahead of plan, although it would be premature to speak of a broad recovery in the injection molding market.
Demand is rising most strongly in the US, where customers are moving ahead with projects postponed in previous years. The expansion of domestic manufacturing is also creating both greenfield and brownfield opportunities.